Moolec Science Completes Key GLASO Commercial Planting, Advances High-GLA Genetics
summarizeSummary
Moolec Science SA announced the successful completion of its 2026 GLASO commercial planting campaign in the United States, focused on high-GLA safflower for specialty oils. This operational milestone demonstrates the company's continued execution and progress towards commercialization, even as it recently disclosed a severe "going concern" warning in its latest financial report. The company also reported advancements in its proprietary genetics program, identifying elite genotypes with over 60% GLA oil concentrations, which could significantly enhance future commercial programs. While positive, this operational update is set against the backdrop of significant liquidity concerns, making future financial and operational updates critical for the company's outlook. The market will closely monitor the crop's performance and the company's strategy to address its financial challenges.
At the time of this announcement, MLEC was trading at $8.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $3.08 to $157.05. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.